Elite Pharmaceuticals Inc. /NV/

CIK: 0001053369

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)1 (50.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ELTP

ELITE PHARMACEUTICALS INC /NV/

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

ELTP
ELITE PHARMACEUTICALS INC /NV/
Aug 25, 2025
Exercise(M)
Direct
2.5M shares at avg. $0.03$75K
ELTP
ELITE PHARMACEUTICALS INC /NV/
Aug 22, 2025
Sale(S)
Direct
500K shares at avg. $0.52$262K

		Type	Shares	Price		Ownership
Aug 25, 2025	ELTP ELITE PHARMACEUTICALS INC /NV/	Exercise(M)	2,500,000	$0.03	$75,000	Direct
Aug 22, 2025	ELTP ELITE PHARMACEUTICALS INC /NV/	Sale(S)	500,000	$0.52	$262,150	Direct

1-2 of 2 transactions

About ELITE PHARMACEUTICALS INC /NV/

ELITE PHARMACEUTICALS INC /NV/ (SEC CIK 0001053369) files insider reports with the SEC as EVP Operations of ELITE PHARMACEUTICALS INC /NV/ (ELTP).

Signal8 holds 1 ownership filing by ELITE PHARMACEUTICALS INC /NV/, a Form 4, filed on Aug 26, 2025. Those filings report 2 transactions, from Aug 22, 2025 to Aug 25, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on ELITE PHARMACEUTICALS INC /NV/'s filings is in NORTHVALE,, NJ.

Recent filings by ELITE PHARMACEUTICALS INC /NV/

Aug 25, 2025: Option exercise of ELTP shares (Form 4, code M).
Aug 22, 2025: Open-market sale of ELTP shares (Form 4, code S).

Other insiders filing for ELITE PHARMACEUTICALS INC /NV/ (ELTP)

Dash Barry H, Director
Plassche Douglas, EVP Operations
Kirkov Kirko, Chief Commercial Officer

How to read Form 4 transaction codes